Newsletters podcasts Audioconferences Live Programs
Home
About MOVE on Mycoses
Fungal Affairs Council
What's New
Fungal Links
Contact Us


Fungal Concepts - Update on Diagnostics and Trends in the Science of Mycology

   1) Fungus in Focus : An Update from ASM 2007
   2) The Echinocandin 'Eagle' Effect and Its Clinical Significance

Program Overview

1) Dr. Elizabeth Dodds Ashley and Dr. John Perfect discuss current data related to the diagnosis, epidemiology, and etiology of fungal infections presented at the 107th General Meeting of the American Society for Microbiology.
2) Dr. Jack Sobel and Dr. James Lewis critically evaluate an important study by Chamilos and colleagues, titled "Paradoxical Effect of Echinocandins Across Candida species In Vitro: Evidence for Echinocandin-specific and Candida Species-related Differences" published in Antimicrobial Agents and Chemotherapy. In the course of their discussion, Drs. Sobel and Lewis debate the clinical significance of this paradoxical or "eagle" effect seen in vitro with echinocandins for Candida species.

Target Audience

This activity has been designed to meet the needs of pharmacists and all other healthcare professionals who care for and who may be involved in the diagnosis, management, and treatment of invasive fungal infections.

Learning Objectives

1) Describe the evolving role of antigen-based and molecular in vitro tests in the timely diagnosis of invasive fungal infections as well as trends in the epidemiology of invasive fungal infections
2) Discuss the clinical significance of the echinocandin “eagle” effect

Faculty

Elizabeth S. Dodds Ashley, PharmD
Assistant Clinical Professor
Campbell University School of Pharmacy
Duke University School of Medicine
Durham, North Carolina

John R. Perfect, MD
Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Jack D. Sobel, MD
Professor of Medicine
Wayne State University School of Medicine
Detroit, Michigan

James S. Lewis, PharmD
Infectious Diseases Pharmacy Programs Manager

Clinical Assistant Professor
University Health System, Department of Pharmacy
University of Texas Health Science Center, San Antonio
San Antonio, Texas


Pharmacist Accreditation

Accreditation Council for Pharmacy EducationThe American Academy of CME (Academy) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Academy has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credit to this activity. ACPE Universal Program Number: 297-999-07-018-HO1-P.

Release Date: Monday, September 10, 2007
Expiration Date: Thursday, October 9, 2008
Estimated Time to Complete Activity: 1 hour

Disclosure Statement

According to the disclosure policy of the Academy, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the Academy to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosures

Elizabeth S. Dodds Ashley, PharmD has received research support from Astellas, Cubist, Enzon, Pfizer, and Schering-Plough. Dr. Dodds Ashley was the co-principal investigator and the funds were paid to Duke, her institution. Additionally, Dr. Dodds Ashley serves as a scientific consultant for Astellas, Enzon, Pfizer and Schering-Plough, and she is a speaker for Astellas, Cubist, Enzon, Pfizer, and Schering-Plough.

John R. Perfect, MD has received research support from Astellas, Enzon, Merck, Pfizer, and Schering-Plough. Dr. Perfect was the principal investigator and the funds were paid to Duke, his institution. Additionally, Dr. Perfect serves as a scientific consultant for Astellas, Enzon, Merck, Pfizer, and Schering-Plough and he serves on the scientific advisory board for Astellas, Enzon, Merck, Pfizer, and Schering-Plough.

Jack D. Sobel, MD has received research support from Astellas, Merck, and Pfizer. Dr. Sobel was the principal investigator and the funds were paid to, Wayne State University, his institution. Additionally, Dr. Sobel serves as a scientific consultant for Pfizer.

James S. Lewis, PharmD serves as a consultant and and is a speaker for Astellas, Pfizer, and Schering-Plough.

Planning Committee Members: Karen Wetzel, American Academy of CME and Vesna Drenovac, RPh, MS, and David Christiansen, PhD, Vemco MedEd have disclosed that they have no relevant financial relationships with any commercial interests.

Off-label Disclosure Statement

Non-FDA approved and investigational use of diagnostics is discussed in "Fungus in Focus: An Update from ASM 2007."

Fee

There is no fee to participate in this educational activity.

Method of Participation

Please note that you must listen to both programs to receive credit. To receive credit for your participation in this CE podcast activity, please complete the following steps:

  1. Review the CE information for both programs including the target audience, learning objectives, and disclosures.
  2. Listen to and review both programs carefully.
  3. Complete the CE Post-test, selecting the most appropriate response to each question.
  4. Complete the CE Evaluation Form and Credit Information.
  5. Fax the Evaluation Form and Credit Information to (609) 921-6428 or mail to: American Academy of CME, 186 Tamarack Circle, Skillman, NJ 08558.  Documentation of credit will be mailed within 6-8 weeks following receipt of your materials.
Listen to “Fungus in Focus : An Update from ASM 2007”
Listen to “The Echinocandin 'Eagle' Effect and Its Clinical Significance”
Download “Fungus in Focus : An Update from ASM 2007” by right clicking and choosing “save target as” or “save link as”
Download “The Echinocandin 'Eagle' Effect and Its Clinical Significance” by right clicking and choosing “save target as” or “save link as”

Download CE forms for this activity


Hardware/Software Requirements

All educational activities are accessible via Internet Explorer and Netscape browsers. A high speed connection is highly recommended. Windows Media Player, sound card, and speakers are required for audio. You must have Adobe Acrobat Reader version 4 or above installed on your computer to view PDF files. If you do not have Acrobat Reader, you can download it for free at
 
    Jointly sponsored by the American Academy of CME, Inc. and Vemco MedEd, LLC

         Supported by an educational grant from Schering-Plough Corporation
 
Copyright © 2007 Vemco MedEd, LLC, All Rights Reserved
Terms of Use | Privacy Policy